Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 799, Issue -, Pages 111-117Publisher
ELSEVIER
DOI: 10.1016/j.ejphar.2017.02.012
Keywords
Chronic muscle pain; Gabapentin; Hyperalgesia; Allodynia; Astrocytes; Microglia
Categories
Funding
- CAPES
- CNPq [467211/2014]
- FAPESP [2014/24533-0]
Ask authors/readers for more resources
In the present work, we investigated the antinociceptive effect of gabapentin in a chronic myositis model and its interference in spinal glial cells. Chronic myositis was induced by injection of Complete Freund Adjuvant (CFA) into the right gastrocnemius (GS) muscle of rats and tests for evaluating mechanical hyperalgesia, thermal hyperalgesia and tactile allodynia were performed. Pharmacological treatment with gabapentin was administrated intrathecally and 100 mu g and 200 mu g doses were tested. For analyzing astrocytes and microglia in the spinal cord, immunochemistry assay was performed. It was found that gabapentin 200 mu g reverted CFA-induced chronic muscle pain bilaterally, in all applied tests and it was able to attenuate microglial but not astrocytes activation in the dorsal horn of spinal cord. In conclusion, gabapentin was able to inhibit hyperalgesia and allodynia in chronic myositis and also to attenuate spinal microglial activation. Therefore, gabapentin could be used as treatment for targeting chronic muscle pain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available